Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Rochelle, Univ Blaise Pascal-Clermont IifiledCriticalUniv La Rochelle
Priority to ARP150100757ApriorityCriticalpatent/AR099750A1/en
Publication of AR099750A1publicationCriticalpatent/AR099750A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Reivindicación 1: Composición que comprende al menos un péptido XAP, en el cual X representa un conjunto vacío o una valina, para su utilización en la prevención y/o el tratamiento de patologías relacionadas con la a-glucosidasa, y especialmente la diabetes de tipo 2.Claim 1: Composition comprising at least one XAP peptide, in which X represents an empty set or a valine, for use in the prevention and / or treatment of pathologies related to a-glucosidase, and especially type diabetes 2.
ARP150100757A2015-03-122015-03-12
COMPOSITIONS FOR THE PREVENTION AND / OR TREATMENT OF PATHOLOGIES RELATED TO A-GLUCOSIDASE
AR099750A1
(en)
Analogs of bicalutamide or (s) - bicalutamide as exocytosis activating compounds for use in the treatment of a lysosomal accumulation disorder or glycogenosis.